Recently, most of the geriatric patients with temporomandibular disorders seen in our department have been treated by providing guidance on diet and daily life and by drug therapy, the same as that for young and middle-aged patients. To assess the efficacy of our treatment of geriatric patients, we conducted a retrospective clinical study on 77 temporomandibular disorders at the age of 65 years of age or over (old group), in comparison with 82 young and middle-aged patients aged 39 years or under (young and middle-age group).
The results showed that in the old group, the treatment was effective in 53 joints (68.8%), and that in 60.4% of the cured patients the signs and symptoms had improved within a month. In the young and middle-age group, treatment was effective in 59 joints (72.0%), and in 67.8% of the cured patients the signs and symptoms had improved within a month.
According to the classification of the Japanese Society of TMJ, in the old group the improvement rate of the type I patients was highest (92.9%), followed by the type III-a patients (80.0%), and type II patients (72.2%). The lowest improvement rate was in the type III-b patients (45.0%). In the young and middle-age group, the improvement rate of the type I patients was highest (100.0%), followed by the type II patients (77.1%), and type III-a patients (76.9%). The lowest improvement rate was in the type III-b patients (43.6%). There were no significant differences between the old group and the young and middle-age group in the improvement rates of any of the TMD types.
Guidance on diet and daily life and the drug therapy were effective, and the period of treatment was relatively short, probably because there were comparatively more type II patients and fewer patients with deformity of the TMJ in the old group.
The results suggest that conservative treatment, mainly guidance on diet and daily life is effective in geriatric patients, the same as in young and middle-age patients.
View full abstract